Artemether; Lumefantrine Patent Expiration
Artemether; Lumefantrine is Used for treating acute, uncomplicated malaria infection caused by Plasmodium falciparum in patients weighing 5kg and above. It was first introduced by Novartis Pharmaceuticals Corp
Artemether; Lumefantrine Patents
Given below is the list of patents protecting Artemether; Lumefantrine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Coartem | US5677331 | Antimalarial compositions |
Oct 14, 2014
(Expired) | Novartis |
Artemether; Lumefantrine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List